However the Department of Health’s chosen vaccine does not protect against genital warts, compared to more expensive vaccines which do.
A report by the Health Protection Agency, published in the British Medical Journal, said despite this, the vaccination programme would be cost-effective, as long as protection against cervical cancer lasted for more than 10 years.
The vaccination programme will start this September when all 12 and 13-year-old girls will be vaccinated, followed by a two year catch-up programme for girls up to 18.
Jane Kim, a professor from Harvard School of Public Health, said in an accompanying editorial that using the cheaper vaccine which does not protect against genital warts meant the Department of Health seemed willing to forgo the health benefits.
Register Now to Continue Reading
Thank you for visiting Children & Young People Now and making use of our archive of more than 60,000 expert features, topics hubs, case studies and policy updates. Why not register today and enjoy the following great benefits:
What's Included
-
Free access to 4 subscriber-only articles per month
-
Email newsletter providing advice and guidance across the sector
Already have an account? Sign in here
